imatinib mesylate has been researched along with Hamartoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, RP; Guo, ZX; Lao, XM; Li, JQ; Wang, GH; Ye, ZY; Zhang, YQ | 1 |
1 other study(ies) available for imatinib mesylate and Hamartoma
| Article | Year |
|---|---|
A gastrointestinal stromal tumor of the jejunum associated with intrahepatic cholangiocarcinoma and pulmonary hamartoma: a case report.
Topics: Antineoplastic Agents; Benzamides; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Gastrointestinal Stromal Tumors; Hamartoma; Humans; Imatinib Mesylate; Jejunal Neoplasms; Lung Diseases; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2009 |